Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules
- Bioorg Med Chem Lett. 2011 Mar 1;21(5):1354-8. doi: 10.1016/j.bmcl.2011.01.043.
Affiliations
- 1. Theravance, Inc., South San Francisco, CA 94080, USA. [email protected]
PMID: 21310610
DOI: 10.1016/j.bmcl.2011.01.043
Abstract
We sought to design dual pharmacology bronchodilators targeting both the M(3) muscarinic acetylcholine and beta-2 adrenergic (β(2)) receptors by applying our multivalent approach to drug discovery. Herein, we describe our initial discovery and the SAR of the first such compounds with matched potencies at both receptors.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area